Timosaponin A1
Cat. No.：YN483298
| 产品名称: | Timosaponin A1 |
| CAS No.: | 68422-00-4 |
| Chemical Name: | (3β,5β,25S)-spirostan-3-yl β-D-galactopyranoside |
| Synonyms: | 知母皂苷A1 |
| 分子量: | 578.78 |
| 分子式: | C₃₃H₅₄O₈ |
| SMILES: | C[C@@]12[C@]3([H])[C@](O[C@]4(CC[C@H](C)CO4)[C@H]3C)([H])C[C@@]1([H])[C@@]5([H])[C@]([C@@]6([C@](C[C@@H](O[C@]7([H])O[C@@H]([C@H](O)[C@H](O)[C@H]7O)CO)CC6)([H])CC5)C)([H])CC2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Timosaponin A1 是从知母中分离出来的一种黄酮类甾体皂苷。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Xie, L., Lee, D.Y.-W., Shang, Y., et al.Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MSPhytomedicine77,153284(2020)
Jiang, S., Wu, X., Wang, Y., et al.The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathwayEur. J. Pharmacol.882,173272(2020)
Carpinteyro Díaz, A.E., Herfindal, L., Rathe, B.A., et al.Cytotoxic saponins and other natural products from flowering tops of Narthecium ossifragum LPhytochemistry164,67-77(2019)
Sun, Y., Liu, L., Peng, Y., et al.Metabolites characterization of timosaponin AIII in vivo and in vitro by using liquid chromatography-mass spectrometryJ. Chromatogr. B Analyt. Technol. Biomed. Life Sci.997,236-243(2015)
